Activities

The Pediatric Virtual Lupus Clinic is a case-based learning activity to help non-rheumatologists recognize, refer, and manage patients with lupus in conjunction with a rheumatologist. You will virtually examine the patient, determine symptoms, decide which labs to order, build the differential diagnosis, and decide next steps for treating the patient, including appropriate referrals, if needed.

  • Case 1 is a 13-year-old Black female with fatigue and joint pain.

  • Case 2 is a 14-year-old Hispanic male with fatigue, facial swelling, and intermittent chest pain.

Pediatric Virtual Lupus Clinic Series

This activity is part of a series. See all activities in the series below:


Target Audience

Primary care providers, advanced practice nurses, physician assistants.


Learning Objectives

Case 1

Upon completion of this activity, participants should be able to:

  • Identify when lupus should be suspected

  • Use appropriate baseline labs and recognize when an ANA is appropriate

  • Describe different skin findings and how differences in skin tones can affect the way a rash looks

  • Implement co-management and referral triaging for a patient

Case 2

Upon completion of this activity, participants should be able to:

  • Identify when lupus should be suspected

  • Identify lupus signs and symptoms and when to suspect renal disease

  • Examine a differential diagnosis for individuals presenting with a combination of renal and pulmonary disease


CE & MOC Information

  • Credit must be claimed by December 1, 2027, at 11:59 PM ET.  

  • By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board. 

  • After submitting a reflective statement with key takeaways from the activity, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you claimed credit. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.

  • All other credit types must be self-reported by the learner to the respective board. Your certificate is your record of credit.

  • All participating healthcare professionals should claim only the credit commensurate with the extent of their participation in this activity. 

Available Credit

  • CME: 1.50 AMA PRA Category 1 Credit(s)™

  • ABIM MOC: 1.50 Medical Knowledge Points

  • ABP MOC: 1.50 Lifelong Learning Points

Designation Statements

Joint Accreditation

In support of improving patient care, the American College of Rheumatology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider Number: 0003797

See the ACR's CE Mission Statement. For more information, download the AMA PRA Booklet

AMA

The ACR designates this enduring activity for a maximum of 4.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine (ABIM) and American Board of Pediatrics (ABP)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program and American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM and ABP MOC credit.


Financial Relationship Disclosures

ACR Disclosure Statement

It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Education (CE) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

In accordance with the ACCME Standards for Integrity and Independence inAccredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CE activity.

Nature of Financial Relationships

All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:

  1. Advisor or review panel member

  2. Consultant

  3. Employee

  4. Officer or Board Member

  5. Grant/research support

  6. Speaker/honoraria includes speaker’s bureau, symposia, and expert witness

  7. Independent contractor

  8. Executive role and/or ownership interest

  9. Royalties and/or patent beneficiary

  10. Intellectual property/patents

  11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan

  12. Private investigator

  13. Expert witness

  14. Equity interest

  15. Other: specify details 

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.

Planning Committee

The following planning committee members have no relevant financial relationship(s) with ineligible companies to disclose.

  • Emily F. Beil, MD

  • Anita Dhanrajani, MBBS, MSc

  • Marla Guzman, MD

  •  Joseph McDonald, MD, MS, RhMSUS

  • Michael Bradley Nelson, MD, MPH

  • Jessica Perfetto, MD

  • Heather Walters, MD

Reviewers

The following reviewers have no relevant financial relationship(s) with ineligible companies to disclose.

  • Sheira Neely, APRN, CPNP

  • Carolyn Zic, APRN, FNP-BC


Acknowledgement of Commercial Support

This activity is supported by the Centers for Disease Control and Prevention (CDC) of the U.S.Department of Health and Human Services (HHS) as part of a financial assistance award of $7 million with 100% funded by CDC/HHS. The activity content was provided by the author(s) and does not necessarily represent the official views of, nor an endorsement by, the CDC/HHS or U.S. Government.


Educational Activity Policies

See ACR educational activity policies, including the online enduring activity refund policy.


Activity Overview

The Pediatric Virtual Lupus Clinic is a case-based learning activity to help non-rheumatologists recognize, refer, and manage patients with lupus in conjunction with a rheumatologist. You will virtually examine the patient, determine symptoms, decide which labs to order, build the differential diagnosis, and decide next steps for treating the patient, including appropriate referrals, if needed.

Case 1 is a 13-year-old Black female with fatigue and joint pain.

Pediatric Virtual Lupus Clinic Series

This activity is part of a series. See all activities in the series below:


Target Audience

Primary care providers, advanced practice nurses, physician assistants.

 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify when lupus should be suspected

  • Use appropriate baseline labs and recognize when an ANA is appropriate

  • Describe different skin findings and how differences in skin tones can affect the way a rash looks

  • Implement co-management and referral triaging for a patient


Price

Registration is complimentary.


CE & MOC Information

Credit must be claimed by December 1, 2027, at 11:59 PM ET. 

  • By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board. 

  • After submitting a reflective statement with key takeaways from the activity, MOC points will be applied for ABIM and/or ABP diplomates to the diplomate number and date of birth provided when you claimed credit. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.

  • The following credit types must be self-reported to the appropriate board: CME, AAPA, AANC, AWSB ACE, and APA. The certificate is a record of your activity completion.

  • All participating healthcare professionals should claim only the credit commensurate with the extent of their participation in this activity. 


Designation Statements

Joint Accreditation

In support of improving patient care, the American College of Rheumatology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider Number: 0003797

See the ACR's CE Mission Statement. For more information, download the AMA PRA Booklet

AMA

The AmericanCollege of Rheumatology designates this Enduring Material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Board of Internal Medicine (ABIM) and American Board of Pediatrics (ABP)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program and American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM and ABP MOC credit.


Financial Relationship Disclosures

ACR Disclosure Statement

It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

In accordance with the ACCME Standards for Integrity and Independence inAccredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.  

Nature of Financial Relationships

All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to: 

  1. Advisor or review panel member

  2. Consultant

  3. Employee

  4. Officer or Board Member

  5. Grant/research support

  6. Speaker/honoraria includes speaker’s bureau,symposia, and expert witness

  7. Independent contractor

  8. Executive role and/or ownership interest

  9. Royalties and/or patent beneficiary

  10. Intellectual property/patents

  11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan

  12. Private investigator

  13. Expert witness

  14. Equity interest

  15. Other: specify details

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.

Planning Committee

The following planning committee members have no relevant financial relationship(s) with ineligible companies to disclose.

  • Emily F. Beil, MD

  • Anita Dhanrajani, MBBS, MSc

  • Marla Guzman, MD

  • Joseph McDonald, MD, MS, RhMSUS

  • Michael Bradley Nelson, MD, MPH

  • Jessica Perfetto, MD

  • Heather Walters, MD

Reviewers

The following reviewers have no relevant financial relationship(s) with ineligible companies to disclose.

  • Sheira Neely, APRN, CPNP

  • Carolyn Zic, APRN,FNP-BC


Acknowledgement of Commercial Support

This activity is supported by the Centers for Disease Control and Prevention (CDC) of the U.S.Department of Health and Human Services (HHS) as part of a financial assistance award of $7 million with 100% funded by CDC/HHS. The activity content was provided by the author(s)and does not necessarily represent the official views of, nor an endorsement by,the CDC/HHS or U.S. Government.


Educational Activity Policies

See ACR educational activity policies, including the online enduring activity refund policy.

Activity Overview

The Pediatric Virtual LupusClinic is a case-based learning activity to help non-rheumatologists recognize, refer, and manage patients with lupus in conjunction with a rheumatologist. You will virtually examine the patient, determine symptoms, decide which labs to order, build the differential diagnosis, and decide next steps for treating the patient, including appropriate referrals, if needed.

Case 2 is a 14-year-old Hispanic male withfatigue, facial swelling, and intermittent chest pain.

Pediatric Virtual Lupus Clinic Series

This activity is part of a series. See all activities in the series below:


Target Audience

Primary care providers, advanced practice nurses, physician assistants.

 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify when lupus should be suspected

  • Identify lupus signs and symptoms and when to suspect renal disease

  • Examine a differential diagnosis for individuals presenting with a combination of renala nd pulmonary disease


Price

Registration is complimentary.


CE & MOC Information

Credit must be claimed by December 1, 2027, at 11:59 PM ET. 

  • By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board. 

  • After submitting a reflective statement with key takeaways from the activity, MOC points will be applied for ABIM and/or ABP diplomates to the diplomate number and date of birth provided when you claimed credit. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.

  • The following credit types must be self-reported to the appropriate board: CME, AAPA, AANC, AWSB ACE, and APA. The certificate is a record of your activity completion.

  • All participating healthcare professionals should claim only the credit commensurate with the extent of their participation in this activity. 


Designation Statements

Joint Accreditation

In support of improving patient care, the American College of Rheumatology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider Number: 0003797

See the ACR's CE Mission Statement. For more information, download the AMA PRA Booklet

AMA

The AmericanCollege of Rheumatology designates this Enduring Material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Board of Internal Medicine (ABIM) and American Board of Pediatrics (ABP)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program and American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM and ABP MOC credit.


Financial Relationship Disclosures

ACR Disclosure Statement

It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

In accordance with the ACCME Standards for Integrity and Independence inAccredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.  

Nature of Financial Relationships

All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to: 

  1. Advisor or review panel member

  2. Consultant

  3. Employee

  4. Officer or Board Member

  5. Grant/research support

  6. Speaker/honoraria includes speaker’s bureau,symposia, and expert witness

  7. Independent contractor

  8. Executive role and/or ownership interest

  9. Royalties and/or patent beneficiary

  10. Intellectual property/patents

  11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan

  12. Private investigator

  13. Expert witness

  14. Equity interest

  15. Other: specify details

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.

Planning Committee

The following planning committee members have no relevant financial relationship(s) with ineligible companies to disclose.

  • Emily F. Beil, MD

  • Anita Dhanrajani, MBBS, MSc

  • Marla Guzman, MD

  • Joseph McDonald, MD, MS, RhMSUS

  • Michael Bradley Nelson, MD, MPH

  • Jessica Perfetto, MD

  • Heather Walters, MD

Reviewers

The following reviewers have no relevant financial relationship(s) with ineligible companies to disclose.

  • Sheira Neely, APRN, CPNP

  • Carolyn Zic, APRN,FNP-BC


Acknowledgement of Commercial Support

This activity is supported by the Centers for Disease Control and Prevention (CDC) of the U.S.Department of Health and Human Services (HHS) as part of a financial assistance award of $7 million with 100% funded by CDC/HHS. The activity content was provided by the author(s)and does not necessarily represent the official views of, nor an endorsement by,the CDC/HHS or U.S. Government.


Educational Activity Policies

See ACR educational activity policies, including the online enduring activity refund policy.